Cargando…

Noncoding RNAs in Cardiac Hypertrophy and Heart Failure

Heart failure is a major global health concern. Noncoding RNAs (ncRNAs) are involved in physiological processes and in the pathogenesis of various diseases, including heart failure. ncRNAs have emerged as critical components of transcriptional regulatory pathways that govern cardiac development, str...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Peilei, Ding, Fan, Xiang, Yang Kevin, Hao, Liying, Zhao, Meimi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908994/ https://www.ncbi.nlm.nih.gov/pubmed/35269399 http://dx.doi.org/10.3390/cells11050777

Ejemplares similares

Silencing of circCacna1c Inhibits ISO-Induced Cardiac Hypertrophy through miR-29b-2-5p/NFATc1 Axis
por: Lu, Peilei, et al.
Publicado: (2023)

Glucose Metabolism in Cardiac Hypertrophy and Heart Failure
por: Tran, Diem H., et al.
Publicado: (2019)

Epigenetics in Cardiac Hypertrophy and Heart Failure
por: Liu, Chia-Feng, et al.
Publicado: (2019)

Circular RNAs in the regulation of cardiac hypertrophy
por: Wu, Siyi, et al.
Publicado: (2021)

The CaMKII phosphorylation site Thr1604 in the Ca(V)1.2 channel is involved in pathological myocardial hypertrophy in rats
por: Li, Jingyuan, et al.
Publicado: (2020)

MicroRNAs in Cardiac Hypertrophy
por: Wehbe, Nadine, et al.
Publicado: (2019)

Role of Irisin in Myocardial Infarction, Heart Failure, and Cardiac Hypertrophy
por: Ho, Ming-Yun, et al.
Publicado: (2021)

Noncoding RNAs in exercise-induced cardio-protection for chronic heart failure
por: Ma, Siyuan, et al.
Publicado: (2019)

Oxidative Stress as A Mechanism for Functional Alterations in Cardiac Hypertrophy and Heart Failure
por: Shah, Anureet K., et al.
Publicado: (2021)

Transcriptome Analysis Reveals Distinct Patterns of Long Noncoding RNAs in Heart and Plasma of Mice with Heart Failure
por: Li, Danhua, et al.
Publicado: (2013)

Inhalation of diesel exhaust does not exacerbate cardiac hypertrophy or heart failure in two mouse models of cardiac hypertrophy
por: Liu, Yonggang, et al.
Publicado: (2013)

Overview of MicroRNAs in Cardiac Hypertrophy, Fibrosis, and Apoptosis
por: Wang, Juan, et al.
Publicado: (2016)

Epigenomic regulation of heart failure: integrating histone marks, long noncoding RNAs, and chromatin architecture
por: McKinsey, Timothy A., et al.
Publicado: (2018)

Angiogenic Endothelial Cell Signaling in Cardiac Hypertrophy and Heart Failure
por: Gogiraju, Rajinikanth, et al.
Publicado: (2019)

Roles of histone acetylation sites in cardiac hypertrophy and heart failure
por: Funamoto, Masafumi, et al.
Publicado: (2023)

Cardiac‐specific ablation of glutaredoxin 3 leads to cardiac hypertrophy and heart failure
por: Donelson, Jimmonique, et al.
Publicado: (2019)

Distinct Circulating Expression Profiles of Long Noncoding RNAs in Heart Failure Patients With Ischemic and Nonischemic Dilated Cardiomyopathy
por: Lin, Fang, et al.
Publicado: (2019)

Non-Coding RNAs in the Therapeutic Landscape of Pathological Cardiac Hypertrophy
por: Silva, Joana, et al.
Publicado: (2022)

Non‐coding RNAs in cardiac hypertrophy
por: Ottaviani, Lara, et al.
Publicado: (2017)

Brain Renin–Angiotensin System in Hypertension, Cardiac Hypertrophy, and Heart Failure
por: Campos, Luciana Aparecida, et al.
Publicado: (2012)

Na(+)/H(+) Exchanger 1, a Potential Therapeutic Drug Target for Cardiac Hypertrophy and Heart Failure
por: Xia, Huiting, et al.
Publicado: (2022)

Noncoding RNAs in Cardiac Autophagy following Myocardial Infarction
por: Turkieh, Annie, et al.
Publicado: (2019)

Long Noncoding RNAs in the Pathogenesis of Insulin Resistance
por: Yang, Weili, et al.
Publicado: (2022)

Noncoding RNAs as Key Regulators for Cardiac Development and Cardiovascular Diseases
por: Kawaguchi, Satoshi, et al.
Publicado: (2023)

Identification of circular RNAs in cardiac hypertrophy and cardiac fibrosis
por: Chen, Yan, et al.
Publicado: (2022)

Role of noncoding RNAs in cardiac ageing
por: Varghese, Lijo N., et al.
Publicado: (2023)

Roles of noncoding RNAs in preeclampsia
por: Sun, Ningxia, et al.
Publicado: (2021)

LncRNAs in cardiac hypertrophy: From basic science to clinical application
por: Liu, Lei, et al.
Publicado: (2020)

Functional importance of cardiac enhancer-associated noncoding RNAs in heart development and disease
por: Ounzain, Samir, et al.
Publicado: (2014)

Challenges and Strategies in Ascribing Functions to Long Noncoding RNAs
por: Zhao, Yang, et al.
Publicado: (2020)

Molecular biomarkers in cardiac hypertrophy
por: Zhu, Liu, et al.
Publicado: (2019)

Decoding Noncoding RNAs: Role of MicroRNAs and Long Noncoding RNAs in Ocular Neovascularization
por: Zhang, Yan, et al.
Publicado: (2017)

Aortocaval Fistula in Rat: A Unique Model of Volume-Overload Congestive Heart Failure and Cardiac Hypertrophy
por: Abassi, Zaid, et al.
Publicado: (2011)

Genetically Modified Mouse Models Used for Studying the Role of the AT(2) Receptor in Cardiac Hypertrophy and Heart Failure
por: Avila, Maria D., et al.
Publicado: (2011)

β-AR Blockers Suppresses ER Stress in Cardiac Hypertrophy and Heart Failure
por: Ni, Li, et al.
Publicado: (2011)

Aberrant Glycosylation in the Left Ventricle and Plasma of Rats with Cardiac Hypertrophy and Heart Failure
por: Nagai-Okatani, Chiaki, et al.
Publicado: (2016)

Early dystrophin loss is coincident with the transition of compensated cardiac hypertrophy to heart failure
por: Prado, Fernanda P., et al.
Publicado: (2017)

Echocardiographic markers of cardiac amyloidosis in patients with heart failure and left ventricular hypertrophy
por: Polo, Jorge Melero, et al.
Publicado: (2023)

Impact of polyphenols on heart failure and cardiac hypertrophy: clinical effects and molecular mechanisms
por: Hedayati, Neda, et al.
Publicado: (2023)

The role of exosomal noncoding RNAs in cancer
por: Xie, Yan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5re6f9uq5k494ld43gr5gj9htk